Table 4 Comparison between benign and malignant lesions.

From: Dual-energy three-compartment breast imaging for compositional biomarkers to improve detection of malignant lesions

Composition

Outer region

Malignant median

Benign median

Median difference

P value

Lipid

1

−2.50e−02

−1.82e−02

−6.82e−03

1.37e−06

Lipid

2

−4.93e−02

−3.74e−02

−1.18e−02

7.49e−08

Lipid

3

−5.56e−02

−4.03e−02

−1.53e−02

8.61e−07

Water

1

−9.39e−03

−1.77e−02

8.36e−03

6.56e−07

Water

2

−9.17e−03

−2.21e−02

1.29e−02

2.43e−07

Water

3

−5.17e−03

−2.22e−02

1.70e−02

4.17e−08

Protein

1

1.23e−02

3.44e−03

8.87e−03

1.73e−08

Protein

2

3.42e−02

1.89e−02

1.52e−02

3.66e−09

Protein

3

3.99e−02

2.33e−02

1.66e−02

7.68e−10

  1. Difference in compositions indicated by the space between blue and orange dashed lines in Fig. 5 are quantified in this table. P values were calculated using a Welch’s test for unequal variance and all p values are significant, indicating that benign and malignant lesions have uniquely different compositions as measured by 3CB.